Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LYTJE/LIFE-CARE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   7.4% 6.4% 5.9% 10.5% 7.1% 12.0% 19.6% 19.2%   Credit score (0-100)   34 38 39 22 33 19 6 7   Credit rating   BB BBB BBB BB BBB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   691 662 584 373 274 267 0.0 0.0   EBITDA   64.0 9.0 48.0 -19.0 158 25.1 0.0 0.0   EBIT   64.0 7.0 44.0 -23.0 154 20.9 0.0 0.0   Pre-tax profit (PTP)   63.0 7.0 43.0 -24.0 152.0 20.1 0.0 0.0   Net earnings   49.0 5.0 34.0 -19.0 119.0 15.3 0.0 0.0   Pre-tax profit without non-rec. items   63.0 7.0 43.0 -24.0 152 20.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 19.0 15.0 11.0 6.0 1.9 0.0 0.0   Shareholders equity total   160 135 168 120 239 154 13.9 13.9   Interest-bearing liabilities   24.0 0.0 4.0 0.0 1.0 1.0 0.0 0.0   Balance sheet total (assets)   301 224 293 203 293 228 13.9 13.9   Net Debt   -131 -85.0 -234 -180 -243 -223 -13.9 -13.9     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   691 662 584 373 274 267 0.0 0.0   Gross profit growth   -9.2% -4.2% -11.8% -36.1% -26.5% -2.4% -100.0% 0.0%   Employees   2 2 2 2 2 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% -50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   301 224 293 203 293 228 14 14   Balance sheet change%   27.0% -25.6% 30.8% -30.7% 44.3% -22.3% -93.9% 0.0%   Added value   64.0 9.0 48.0 -19.0 158.0 25.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 17 -8 -8 -9 -8 -2 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.3% 1.1% 7.5% -6.2% 56.2% 7.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   23.8% 2.7% 17.0% -9.3% 62.1% 8.4% 0.0% 0.0%   ROI %   40.9% 4.4% 28.7% -15.8% 85.3% 11.0% 0.0% 0.0%   ROE %   36.2% 3.4% 22.4% -13.2% 66.3% 7.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   53.2% 60.3% 57.3% 59.1% 81.6% 67.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -204.7% -944.4% -487.5% 947.4% -153.8% -888.3% 0.0% 0.0%   Gearing %   15.0% 0.0% 2.4% 0.0% 0.4% 0.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.8% 0.0% 50.0% 50.0% 400.0% 172.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.1 2.3 2.2 2.3 5.4 3.1 0.0 0.0   Current Ratio   2.1 2.3 2.2 2.3 5.4 3.1 0.0 0.0   Cash and cash equivalent   155.0 85.0 238.0 180.0 244.0 223.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   160.0 116.0 153.0 109.0 234.0 152.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   32 5 24 -10 79 25 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   32 5 24 -10 79 25 0 0   EBIT / employee   32 4 22 -12 77 21 0 0   Net earnings / employee   25 3 17 -10 60 15 0 0